Evidence map›Paper›PMID 35712691›Full record

ArticleJournal of community hospital internal medicine perspectives2022

Pulmonary Evaluation of Post-COVID-19 Patients: An Ecuadorian Experience.

Ivan Cherrez-Ojeda, Efraín Sanchez-Angarita, Emanuel Vanegas, María J Farfán Bajaña, Karla Robles-Velasco, María F Osorio, Azza Sarfraz, Zouina Sarfraz, Juan C Calderón, Jorge Cáneva and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of community hospital internal medicine perspectives, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Ivan Cherrez-OjedaUniversidad Espíritu Santo, Samborondón, Ecuador.
Efraín Sanchez-AngaritaCentro de Investigación Respiratoria (CIR), Guayaquil, Ecuador.
Emanuel VanegasUniversidad Espíritu Santo, Samborondón, Ecuador.
María J Farfán BajañaUniversidad Espíritu Santo, Samborondón, Ecuador.
Karla Robles-VelascoUniversidad Espíritu Santo, Samborondón, Ecuador.
María F OsorioUniversidad Espíritu Santo, Samborondón, Ecuador.
Azza SarfrazDepartment of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Zouina SarfrazResearch & Publications, Fatima Jinnah Medical University, Lahore, Pakistan.
Juan C CalderónRespiralab, Respiralab Research Group, Guayaquil, Ecuador.
Jorge CánevaJefe de Neumología, Hospital Universitario Fundación Favaloro, Ciudad Autónoma de Buenos Aires, Argentina.
Laura Gochicoa-RangelDepartamento de Fisiología Respiratoria, Instituto Nacional de Enfermedades Respiratorias, "Ismael Cosío Villegas", Ciudad de México, Mexico.
Matías P LascanoRespiralab, Respiralab Research Group, Guayaquil, Ecuador.
Juan C Fernández CadenaOmics Sciences Laboratory, Universidad Espíritu Santo, Samborondón, Ecuador.
Derly M Andrade MolinaOmics Sciences Laboratory, Universidad Espíritu Santo, Samborondón, Ecuador.
Amado X FreireUniversity of Tennessee Health Science Center, Tennessee, United States.
Miguel FelixUniversidad Espíritu Santo, Samborondón, Ecuador.
Universidad de Especialidades Espíritu Santo · ECAga Khan University · PKFatima Jinnah Medical University · PKUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite the growing concerns related to the potential of long-term pulmonary sequelae due to COVID-19, data about intermediate and long-term changes in the respiratory function of patients who recover is relatively sparse, particularly in developing countries. Objectives: To assess the characteristics and pulmonary function at follow-up in a sample of Ecuadorian patients that recovered from the virus. Methods: We conducted a cross-sectional study that included 43 patients after symptomatic COVID infection, who were evaluated by spirometry, single breath DLCO, and 6MWT. For statistical analysis we performed point biserial correlations, and chi squared tests. Results: Overall, 30.3% of patients (n = 13) reported persistent symptoms, with fatigue being the most common (23.3%, n = 10). Around 34.9% (n = 15) of the sample had a restrictive spirometry pattern, 18.6% (n = 8) had an abnormally decreased adjusted DLCO. A restrictive spirometry pattern was associated with an abnormally low adjusted DLCO (χ Conclusion: We found that a considerable proportion of patients presented with persistent symptoms and alterations in pulmonary function following COVID-19, mainly a restrictive respiratory pattern and abnormally low DLCO. Further studies are needed to determine which patients may benefit from the follow-up with specific pulmonary function tests.

Indexed as

COVID-19DLCOInterstitial lung diseasePulmonary function testsSouth America

Identifiers

PMID35712691
PMCPMC9195060
OpenAlexW4226518628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.